Laboratory Corporation of America
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Laboratory Corporation of America
VC Playbook: Finding Early-Stage Financing When Money Is Scarce
Early-stage companies need to be more flexible on the financing terms they are willing to accept and in finding ways to gather evidence to support the impact of their products or services.
Finance Watch: Aileron, Talaris, Frequency And The Search For Strategic Alternatives
Public Company Edition: Aileron, Talaris and Frequency said they will reduce expenses and seek options for maximizing shareholder returns under tough stock market conditions. However, CureVac and Supernus are among firms recently able to access new cash – $250m and $150m, respectively.
Tech Transfer Roundup: MD Anderson, Replay Found Allogeneic TCR-NK Cell Therapy Play Syena
Start-up hopes to bring its first candidate, an NY-ESO-1-targeting off-the-shelf product, into the clinic in Q2. Astex and Cardiff University team up on novel therapies for neurodegenerative disease.
Deal Watch: BMS Returning IL-12 Candidate To Frequent Partner Dragonfly
The firms’ partnership goes back to pre-merger Celgene, and BMS still has Dragonfly candidates in its pipeline. Ji Xing gets hypertension candidate from Phase Bio.
- Contract Research Organization-CRO
- In Vitro Diagnostics
- Laboratory Testing Services
- Medical Devices
- Other Names / Subsidiaries
- Alpha Medical Laboratories
- Covance Inc.
- Colorado Laboratory Services
- Kentucky Laboratory Services
- Medtox Scientific
- Monogram Biosciences
- Mount Sinai Health System Clinical Outreach Laboratories
- MountainStar Clinical Laboratories
- PACLAB Network Laboratories
- Pathology Associates Medical Laboratories
- Personal Genome Diagnostics Inc.
- SensiGen LLC
- Sequenom, Inc.
- Tri-Cities Laboratory
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.